ATP synthase subunit-β down-regulation aggravates diabetic nephropathy

Area of Science:

• Nephrology
• Biochemistry
• Cell Biology

Background:

• Diabetic nephropathy is a major complication of diabetes.
• The role of ATP synthase subunit-β (ATP5b) in diabetic kidney disease is not fully understood.

Purpose of the Study:

• To investigate the role of ATP synthase subunit-β (ATP5b) in diabetic nephropathy.
• To elucidate the mechanisms by which ATP5b influences renal fibrosis.

Main Methods:

• Comparison of kidney histopathology, fibrosis, and protein expression (α-SMA, AGEs, ATP5b) in db/db diabetic mice and control mice.
• In vitro studies using cultured renal tubular cells treated with advanced glycation end-products (AGEs) and ATP5b-siRNA.
• Assessment of oxidative stress markers and cellular ATP content.
• Evaluation of the effect of N-acetylcysteine and ATP5b-siRNA on fibrotic markers and gene expression.

Main Results:

• Diabetic kidneys showed increased histopathological changes, fibrosis, α-smooth muscle actin (α-SMA), advanced glycation end-products (AGEs), and ATP5b, primarily in tubules.
• AGEs increased ATP5b and fibrotic factors, decreased ATP content, and induced oxidative stress in renal tubular cells via an AGEs-receptor for AGEs (RAGE) pathway.
• Antioxidant N-acetylcysteine reversed AGEs-induced increases in ATP5b and CTGF.
• ATP5b-siRNA transfection exacerbated AGEs-induced α-SMA and CTGF expression and promoter activity.
• In vivo ATP5b down-regulation via siRNA enhanced renal fibrosis and serum creatinine in diabetic mice.

Conclusions:

• Increased ATP5b expression in diabetic kidneys appears to play an adaptive or protective role.
• ATP5b may mitigate AGEs-induced renal fibrosis, potentially through mechanisms involving oxidative stress regulation.